CVS Group shares surge over 10% after FY25 EBITDA beats estimates
Director Jason C. Rebrook of Archrock, Inc. (NYSE:AROC), a $4.2 billion market cap company with strong financial health according to InvestingPro metrics, purchased 10,000 shares of common stock on September 19, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were bought at prices ranging from $24.12 to $24.20, averaging $24.158, for a total transaction value of $241,580. Following the transaction, Rebrook directly owns 74,511 shares of Archrock. The company maintains a 3.49% dividend yield and has consistently paid dividends for 12 consecutive years. Analysts have set price targets between $30-32, suggesting potential upside. Get detailed valuation analysis and 8 additional key insights with InvestingPro’s comprehensive research report.
In other recent news, Archrock Inc. reported its second-quarter 2025 earnings, surpassing Wall Street expectations with an earnings per share (EPS) of $0.39, slightly above the forecast of $0.38. The company also posted a revenue of $383.2 million, exceeding predictions of $364.08 million. Stifel raised its price target for Archrock to $30.00 from $29.00, maintaining a Buy rating, following the company’s financial results, which were deemed satisfactory despite not exceeding revenue and margin expectations. Evercore ISI adjusted its price target to $31.00 from $32.00, while keeping an Outperform rating, noting strong demand across all service territories. Wells Fargo initiated coverage on Archrock with an Overweight rating, emphasizing the company’s potential benefits from U.S. natural gas supply growth. Additionally, Archrock announced a dual listing of its common stock on the newly launched NYSE Texas exchange, while maintaining its primary listing on the New York Stock Exchange. These developments reflect the company’s strategic positioning and market engagement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.